Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 18F-FET PET/MRI for CNS-tumors in children and adolescents

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Fatma E El-Khouly
  • Sophie E M Veldhuijzen van Zanten
  • Vicente Santa-Maria Lopez
  • N Harry Hendrikse
  • Gertjan J L Kaspers
  • G Loizos
  • David Sumerauer
  • Karsten Nysom
  • Kaie Pruunsild
  • Virve Pentikainen
  • Halldora K Thorarinsdottir
  • Giedre Rutkauskiene
  • Victor Calvagna
  • Monika Drogosiewicz
  • Monica Dragomir
  • Ladislav Deak
  • Lidija Kitanovski
  • Andre O von Bueren
  • Rejin Kebudi
  • Irene Slavc
  • Sandra Jacobs
  • Filip Jadrijevic-Cvrlje
  • Natacha Entz-Werle
  • Jacques Grill
  • Antonis Kattamis
  • Peter Hauser
  • Jane Pears
  • Veronica Biassoni
  • Maura Massimino
  • Enrique Lopez Aguilar
  • Ingrid K Torsvik
  • Maria Joao Gil-da-Costa
  • Ella Kumirova
  • Ofelia Cruz-Martinez
  • Stefan Holm
  • Simon Bailey
  • Tim Hayden
  • Ulrich W Thomale
  • Geert O R Janssens
  • Christof M Kramm
  • Dannis G van Vuurden
View graph of relations

INTRODUCTION: Diffuse intrinsic pontine glioma (DIPG) is a rare clinically, neuro-radiologically, and molecularly defined malignancy of the brainstem with a median overall survival of approximately 11 months. Our aim is to evaluate the current tendency for its treatment in Europe in order to develop (inter)national consensus guidelines.

METHODS: Healthcare professionals specialized in DIPG were asked to fill in an online survey with questions regarding usual treatment strategies at diagnosis and at disease progression in their countries and/or their centers, respectively.

RESULTS: Seventy-four healthcare professionals responded to the survey, of which 87.8% were pediatric oncologists. Only 13.5% of the respondents biopsy all of their patients, 41.9% biopsy their patients infrequently. More than half of the respondents (54.1%) treated their patients with radiotherapy only at diagnosis, whereas 44.6% preferred radiotherapy combined with chemotherapy. When the disease progresses, treatment strategies became even more diverse, and the tendency for no treatment increased from 1.4% at diagnosis to 77.0% after second progression. 36.5% of the healthcare professionals treat children younger than 3 years differently than older children at diagnosis. This percentage decreased, when the disease progresses. Most of the participants (51.4%) included less than 25% of their patients in clinical trials.

CONCLUSION: This survey demonstrates a large heterogeneity of treatment regimens, especially at disease progression. We emphasize the need for international consensus guidelines for the treatment of DIPG, possible by more collaborative clinical trials.

Original languageEnglish
JournalJournal of Neuro-Oncology
Volume145
Issue number1
Pages (from-to)177-184
Number of pages8
ISSN0167-594X
DOIs
Publication statusPublished - 2019

ID: 59001643